Diphenidol-related diamines as novel muscarinic M4 receptor antagonists

被引:12
|
作者
Varoli, Lucilla [1 ]
Andreani, Aldo [1 ]
Burnelli, Silvia [1 ]
Granaiola, Massimiliano [1 ]
Leoni, Alberto [1 ]
Locatelli, Alessandra [1 ]
Morigi, Rita [1 ]
Rambaldi, Mirella [1 ]
Bedini, Andrea [2 ]
Fazio, Nicola [2 ]
Spampinato, Santi [2 ]
机构
[1] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy
[2] Univ Bologna, Dept Pharmacol, I-40126 Bologna, Italy
关键词
M-4-selective muscarinic antagonists; diphenidol diamine derivatives; muscarinic receptor binding assays; functional studies; allosteric modulation;
D O I
10.1016/j.bmcl.2008.03.061
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of hydrochloride derivatives 2a-9a and quaternary ammonium derivatives 3b-9b of diphenidol have been synthesized and characterized in receptor binding and cellular functional assays versus human muscarinic M-1-M-5 receptors expressed in CHO cells. Compound 8b, a methiodide derivative with a bipiperidinyl moiety and a second diphenidol framework, showed a potent and selective M-4 activity as competitive antagonist. Moreover 8b, acting as an allosteric modulator, was able to retard the dissociation rate of [H-3]-N-methylscopolamine from CHO-M-4 cell membranes exposed to atropine. Taken together, these data suggest that 8b might open new avenues to the discovery of novel multivalent antagonists for the muscarinic receptors. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2972 / 2976
页数:5
相关论文
共 50 条
  • [1] Synthesis and pharmacological profile of a series of 1-substituted-2-carbonyl derivatives of diphenidol:: Novel M4 muscarinic receptor antagonists
    Varoli, Lucilla
    Angeli, Piero
    Buccioni, Michela
    Burnelli, Silvia
    Fazio, Nicola
    Marucci, Gabriella
    Recanatini, Maurizio
    Spampinato, Santi
    MEDICINAL CHEMISTRY, 2008, 4 (02) : 121 - 128
  • [2] Benzoxazine isoquinolines as M4 selective muscarinic receptor antagonists
    Schwarz, RD
    Boehme, TM
    Augelli-Szafran, CE
    Moreland, DW
    LIFE SCIENCES, 2001, 68 (22-23) : 2626 - 2626
  • [3] Development of Novel M4 Muscarinic Acetylcholine Receptor Antagonists for the Treatment of Movement Disorders
    Rook, Jerri
    Bender, Aaron
    Dickerson, Jonathan
    Foster, Daniel
    Rodriguez, Alice
    Niswender, Colleen
    Hess, Ellen
    Conn, Jeff
    Lindsley, Craig
    FASEB JOURNAL, 2022, 36
  • [4] Benzoxazine isoquinoline as m4 selective muscarinic receptor antagonists.
    Boehme, TM
    Augelli-Szafran, CE
    Moreland, DW
    Schwarz, RD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U565 - U565
  • [5] Identification and characterization of m4 selective muscarinic antagonists
    Augelli-Szafran, CE
    Jaen, JC
    Moreland, DW
    Nelson, CB
    Penvose-Yi, JR
    Schwarz, RD
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (15) : 1991 - 1996
  • [6] Identification and characterization of m4 selective muscarinic antagonists
    AugelliSzafran, CE
    Moreland, DW
    Nelson, CB
    PenvoseYi, JR
    Schwarz, RD
    Jean, JC
    LIFE SCIENCES, 1997, 60 (13-14) : 11 - 11
  • [7] Role of M1 and M4 receptors in development of myopia:: Study with muscarinic receptor antagonists and muscarinic toxins
    Diether, S
    Schaeffel, F
    Fritsch, C
    Trendelenburg, AU
    Payor, R
    Lambrou, GN
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [8] SELECTIVE LABELING AND LOCALIZATION OF THE M4 (M4) MUSCARINIC RECEPTOR SUBTYPE
    FERRARIDILEO, G
    WAELBROECK, M
    MASH, DC
    FLYNN, DD
    MOLECULAR PHARMACOLOGY, 1994, 46 (06) : 1028 - 1035
  • [9] Investigations into the physiological role of muscarinic M2 and M4 muscarinic and M4 receptor subtypes using receptor knockout mice
    Bymaster, FP
    Carter, PA
    Zhang, L
    Falcone, JF
    Stengel, PW
    Cohen, ML
    Shannon, HE
    Gomeza, J
    Wess, J
    Felder, CC
    LIFE SCIENCES, 2001, 68 (22-23) : 2473 - 2479
  • [10] Analogs of M4 selective synthetic muscarinic receptor antagonists:: Synthesis, binding and pharmacokinetic properties
    Böhme, TM
    Augelli-Szafran, CE
    Hallak, H
    Schwarz, RD
    MEDICINAL CHEMISTRY RESEARCH, 2002, 11 (08) : 423 - 433